An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System

An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System Drug Saf (2017) 40:799–808 DOI 10.1007/s40264-017-0550-1 OR IGINAL RESEARCH ARTIC L E An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System 1 2,3 2,4,5 6 • • • Geetha Iyer Sathiya Priya Marimuthu Jodi B. Segal Sonal Singh Published online: 7 June 2017 Springer International Publishing Switzerland 2017 Abstract number/abbreviated NDA (ANDA), and specific use of the Introduction Although generic drugs constitute approxi- term ‘generic’ or ‘brand’ to classify the focal drug of each mately 88% of drugs prescribed in the US, there are no case report as definitely generic (two of three criteria), reliable methods to identify generic drugs in the US FDA probably generic (one of three criteria), brand, and cannot Adverse Event Reporting System (FAERS). be assessed. Inter-rater reliability was estimated using Objective The aim of this study was to develop an algo- kappa coefficients, and internal consistency was estimated rithm for identifying generic drugs in the FAERS. using Cronbach’s alpha. We compared the classification of Data Source We used 1237 adverse event reports for the drugs as generic versus non-generic in publicly avail- tamsulosin, levothyroxine, and amphetamine/dextroam- able FAERS compared with the original case reports phetamine from the publicly available FAERS http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drug Safety Springer Journals

An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System

Loading next page...
 
/lp/springer_journal/an-algorithm-to-identify-generic-drugs-in-the-fda-adverse-event-mwlUDQD2iz
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-5916
eISSN
1179-1942
D.O.I.
10.1007/s40264-017-0550-1
Publisher site
See Article on Publisher Site

Abstract

Drug Saf (2017) 40:799–808 DOI 10.1007/s40264-017-0550-1 OR IGINAL RESEARCH ARTIC L E An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System 1 2,3 2,4,5 6 • • • Geetha Iyer Sathiya Priya Marimuthu Jodi B. Segal Sonal Singh Published online: 7 June 2017 Springer International Publishing Switzerland 2017 Abstract number/abbreviated NDA (ANDA), and specific use of the Introduction Although generic drugs constitute approxi- term ‘generic’ or ‘brand’ to classify the focal drug of each mately 88% of drugs prescribed in the US, there are no case report as definitely generic (two of three criteria), reliable methods to identify generic drugs in the US FDA probably generic (one of three criteria), brand, and cannot Adverse Event Reporting System (FAERS). be assessed. Inter-rater reliability was estimated using Objective The aim of this study was to develop an algo- kappa coefficients, and internal consistency was estimated rithm for identifying generic drugs in the FAERS. using Cronbach’s alpha. We compared the classification of Data Source We used 1237 adverse event reports for the drugs as generic versus non-generic in publicly avail- tamsulosin, levothyroxine, and amphetamine/dextroam- able FAERS compared with the original case reports phetamine from the publicly available FAERS

Journal

Drug SafetySpringer Journals

Published: Jun 7, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off